Madrigal Pharmaceuticals, Inc. Share Price
Equities
MDGL
US5588681057
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 433.20 USD | +0.09% |
|
-0.56% | -25.61% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"
| Capitalization | 9.94B 8.57B 7.74B 7.42B 13.48B 916B 14.1B 91.39B 36.65B 438B 37.3B 36.5B 1,572B | P/E ratio 2026 * |
-87x | P/E ratio 2027 * | 33.4x |
|---|---|---|---|---|---|
| Enterprise value | 9.39B 8.1B 7.32B 7.01B 12.74B 865B 13.32B 86.37B 34.64B 414B 35.26B 34.5B 1,485B | EV / Sales 2026 * |
6.33x | EV / Sales 2027 * | 4.21x |
| Free-Float |
91.44% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Madrigal Pharmaceuticals, Inc.
| 1 day | +0.09% | ||
| 1 week | -0.56% | ||
| Current month | +0.28% | ||
| 1 month | -11.28% | ||
| 3 months | -21.79% | ||
| 6 months | -3.46% | ||
| Current year | -25.61% |
| 1 week | 418.72 |  | 444.43 |
| 1 month | 416.21 | | 498.1 |
| Current year | 416.21 | | 598.79 |
| 1 year | 265 | | 615 |
| 3 years | 119.76 | | 615 |
| 5 years | 52.33 | | 615 |
| 10 years | 6.6 | | 615 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Sibold
CEO | Chief Executive Officer | 59 | 07/09/2023 |
Edward Chiang
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/2011 |
Mardi Dier
DFI | Director of Finance/CFO | 62 | 10/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Friedman
CHM | Chairman | 83 | 21/07/2016 |
Rebecca Taub
BRD | Director/Board Member | 73 | 30/06/2016 |
Ken Bate
BRD | Director/Board Member | 75 | 21/07/2016 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.09% | -0.56% | +30.71% | +69.62% | 9.94B | |
| +2.16% | -0.03% | +21.27% | +99.26% | 44.74B | |
| -2.36% | -5.14% | +45.74% | +12.82% | 39.46B | |
| +2.14% | -2.18% | +91.12% | +653.32% | 30.85B | |
| +0.65% | -4.95% | -6.09% | -19.74% | 25.64B | |
| +3.39% | -1.03% | +54.19% | -29.58% | 18.74B | |
| +2.90% | +0.28% | +16.36% | -28.12% | 16.45B | |
| +10.90% | +15.52% | +64.76% | +192.62% | 12.22B | |
| +4.04% | -2.90% | -11.59% | +1,007.04% | 12.19B | |
| +8.84% | +17.70% | +68.13% | - | 11.33B | |
| Average | +3.27% | -3.22% | +37.46% | +217.47% | 22.16B | |
| Weighted average by Cap. | +2.17% | -3.43% | +38.02% | +185.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.48B 1.28B 1.16B 1.11B 2.01B 137B 2.1B 13.64B 5.47B 65.35B 5.57B 5.45B 235B | 2.14B 1.84B 1.66B 1.6B 2.9B 197B 3.03B 19.65B 7.88B 94.16B 8.02B 7.85B 338B |
| Net income | -122M -105M -94.77M -90.82M -165M -11.21B -173M -1.12B -449M -5.36B -457M -447M -19.24B | 336M 290M 262M 251M 456M 30.94B 476M 3.09B 1.24B 14.8B 1.26B 1.23B 53.11B |
| Net Debt | -546M -471M -425M -407M -740M -50.27B -774M -5.02B -2.01B -24.05B -2.05B -2B -86.29B | -941M -812M -733M -703M -1.28B -86.72B -1.34B -8.66B -3.47B -41.48B -3.53B -3.46B -149B |
Employees
915
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/03/26 | 433.20 $ | +0.09% | 288,858 |
| 06/03/26 | 432.83 $ | -1.48% | 476,025 |
| 05/03/26 | 439.34 $ | +1.04% | 275,373 |
| 04/03/26 | 434.80 $ | +2.10% | 265,111 |
| 03/03/26 | 425.85 $ | -2.24% | 287,865 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
433.20USD
Average target price
667.57USD
Spread / Average Target
+54.10%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MDGL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition